Full text is available at the source.
Abstract
The optimized α-Cy-SLNs exhibited a mean particle size of 279.5 ± 0.06 nm and an entrapment efficiency of 70.0 ± 2.21%.
- The formulation demonstrated a polydispersity index of 0.203 ± 0.24 and a zeta potential of -23.1 ± 2.38 mV, indicating favorable stability characteristics.
- Sustained release of α-Cy from the solid lipid nanoparticles suggests potential for prolonged drug delivery.
- Incorporation into a thermosensitive gel is associated with controlled release and enhanced bioavailability.
- The α-Cy-SLN gel formulation may enhance bioavailability and therapeutic potential for neuroprotection in Alzheimer's disease.
Simplified